This move is archived. Current quotes and coverage live on the stock page.
Get TELY alerts:
TelyRx Holdings Inc. shares surged by over 22% in the latest trading session, reflecting strong investor interest.
In a remarkable one-day performance, TelyRx Holdings Inc. (TELY.TO) saw its stock price jump by 22.45%, closing at CA$3.00. This surge comes amid increasing investor enthusiasm following the company's recent developments.
Investor takeaway: Investors should consider the implications of TelyRx's stock surge and monitor any forthcoming announcements that could impact its trajectory.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$59.83M
52W high
$4.25
52W low
$2.00
1W change
-4.26%
Analyst Price Targets
Based on analyst covering TELY · as of Sep 17, 2026
Wall Street analysts forecast TELY stock price to rise 166.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+166.7% Upside
Current Price
C$2.25
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
81.3%
Annualized
90-Day Vol
97.6%
Annualized
Trend (90d)
-35.8%
Annualized drift
90d Mean
C$1.98
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.16 | C$1.63 – C$2.85 |
| 60 trading days | C$2.07 | C$1.39 – C$3.07 |
| 90 trading days | C$1.98 | C$1.22 – C$3.22 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
TelyRx Holdings Inc. Stock Up 22.45%
Advertisement
With a market cap of CA$65.12 million, TelyRx's significant one-day gain highlights its potential volatility and investor interest.
Bull case
The recent spike in TelyRx's stock price suggests that investors are growing more confident in the company's future. This optimism follows TelyRx's transition to the Toronto Stock Exchange and its recent financial disclosures, which may have reassured investors about its prospects.
Bear case
Despite the positive movement, TelyRx's ongoing losses and lack of dividends could raise concerns about its long-term sustainability and profitability. Investors should weigh these risks carefully before making decisions.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
